Overview: Quantum computing has moved from research labs to surging stock valuations and massive investment flows, with some ...

WhiteSands Alcohol & Drug Rehab has released a new educational resource on its website that examines “how Aetna insurance ...

Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI) ...

Historically, ethnopharmacology has served as a bridge between traditional knowledge systems and modern drug discovery, providing critical leads for the ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

The molecular combinations involved in creating new treatments are vast, so Nvidia is customizing its technology to address ...

Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...